HypeCheck

Acetyl L-Carnitine

Also known as: ALCAR, Acetyl-L-Carnitine, ALC, N-Acetyl Carnitine

Effective Dosage

No established dose from provided studies

What the Science Says

Acetyl L-Carnitine (ALCAR) is a naturally occurring compound derived from the amino acid carnitine. It plays a role in transporting fatty acids into mitochondria for energy production and has antioxidant properties. The provided research suggests potential roles in metabolic support (in PCOS when combined with other nutrients), adjunctive use in certain poisonings, and pre-clinical anti-tumor activity in colorectal cancer models — though most findings are preliminary or studied in combination with other compounds.

What It Doesn't Do

Won't reliably boost athletic performance — a cycling study found no aerobic or anaerobic benefit. Won't improve IVF pregnancy rates when added to culture media. No strong evidence it works as a standalone cognitive enhancer. Don't expect it to replace proven medications for any condition. Anti-cancer effects are only seen in lab and animal studies — not in humans yet.

Evidence-Based Benefits

ALCAR plays a role in mitochondrial fatty acid metabolism and exhibits antioxidant properties; preclinical evidence (PMID: 41610723) suggests it may inhibit colorectal cancer cell proliferation and induce apoptosis in vitro and in mouse models, though human evidence is lacking. As an adjunct in poisoning scenarios (PMID: 41692009), LC/ALC shows some clinically relevant effects in organophosphate and aluminum phosphide poisoning by reducing oxidative stress and supporting mitochondrial function. In a PCOS combination trial (PMID: 41026176), a nutraceutical blend including ALCAR improved metabolic and hormonal outcomes, though the individual contribution of ALCAR cannot be isolated.

Weak Evidence

Effective at: No established dose from provided studies

Source: auto-research

Absorption & Bioavailability

Unknown from provided studies — no pharmacokinetic data was included in the provided papers. General absorption is considered moderate when taken orally, but this is not confirmed by the provided evidence.

Red Flags to Watch For

  • ALCAR is a precursor to TMAO (trimethylamine N-oxide), a gut-derived metabolite associated with cardiovascular risk — one study found elevated TMAO in ALS patients taking ALCAR supplementation
  • Most positive findings come from combination products (with CoQ10, L-Arginine, selenium, etc.), making it impossible to isolate ALCAR's specific contribution
  • When combined with donepezil for cognitive decline, the ALCAR group showed worse cognitive scores than donepezil alone in one trial
  • Evidence base relies heavily on animal and pre-clinical studies — human RCT data in the provided papers is sparse and often confounded by multi-ingredient formulas
  • Long-term safety data, especially regarding TMAO-related cardiovascular effects, is not addressed in the provided studies

Research Sources

  • PubMed
  • NIH DSLD

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06